Central Asian Research Index

West Kazakhstan Regenerative Medicine Journal, 2026, т. 14, № 2, с. 135-154

Precision Perinatal Secretomics: Umbilical Cord Mesenchymal Stem Cell-derived Secretome as a Cell-free Therapeutic Platform for Maternal–Fetal Interface Disorders – A Narrative Synthesis

Wiku Andonotopo, Muhammad Adrianes Bachnas, Wisnu Prabowo, Eric Edwin Yuliantara, Mochammad Besari Adi Pramono, Julian Dewantiningrum, Efendi Lukas, I. Nyoman Hariyasa Sanjaya, Anak Agung Gede Putra Wiradnyana, Anak Agung Ngurah Jaya Kusuma, Khanisyah Erza Gumilar, Ernawati Darmawan, Muhammad Ilham Aldika Akbar, Dovy Djanas, Dudy Aldiansyah, Aloysius Suryawan, Ridwan Abdullah Putra, Theresia Monica Rahardjo, Rizna Tyrani Rumanti, Roland Frederik Lengkey, Anita Deborah Anwar, Aryani Aziz, Nuswil Bernolian, Cut Meurah Yeni, Laksmana Adi Krista Nugraha, Wibisana Andika Krista Dharma, Waskita Ekamaheswara Kasumba Andanaputra

Department of Obstetrics and Gynecology, Fetomaternal Division, Women Health Center, Eka Hospital BSD City, Tangerang, Banten, Indonesia
Department of Obstetrics and Gynecology, Fetomaternal Division, Medical Faculty of Sebelas Maret University, Dr. Moewardi Hospital, Solo, Surakarta, Indonesia
Department of Obstetrics and Gynecology, Fetomaternal Division, Medical Faculty of Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia
Department of Obstetrics and Gynecology, Fetomaternal Division, Faculty of Medicine, Hasanuddin University of Makassar, Makassar, Indonesia
Department of Obstetrics and Gynecology, Maternal-Fetal Medicine Division, Faculty of Medicine, Udayana University, Prof. dr. I.G.N.G Ngoerah General Hospital, Bali, Indonesia
Department of Obstetrics and Gynecology, Maternal-Fetal Medicine Division, Faculty of Medicine, Airlangga University, Dr. Soetomo Hospital, Surabaya, Indonesia
Department of Obstetrics and Gynecology, Fetomaternal Division, Faculty of Medicine, Andalas University, M. Djamil General Hospital, Padang, West Sumatera, Indonesia
Department of Obstetrics and Gynecology, Fetomaternal Division, Faculty of Medicine, Sumatera Utara University, H. Adam Malik General Hospital, Medan, North Sumatera, Indonesia
Department of Obstetrics and Gynecology, Fetomaternal Division, Faculty of Medicine, Maranatha Christian University, Bandung, West Java, Indonesia
Department of Obstetrics and Gynecology, Maternal-Fetal Medicine Division, Faculty of Medicine, Padjadjaran University, Hasan Sadikin Hospital, Bandung, West Java, Indonesia
Department of Obstetrics and Gynecology, Maternal-Fetal Medicine Division, Faculty of Medicine, Sriwijaya University, Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
Department of Obstetrics and Gynecology, Maternal-Fetal Medicine Division, Faculty of Medicine, Syiah Kuala University, Dr. Zainoel Abidin General Hospital, Aceh, Indonesia
Department of Medicine, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
Department of Medicine, Undergraduate Program in Medical Science, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia
Department of Medicine, Undergraduate Program in Medical Science, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia

Аннотация · Abstract

A BSTRACT Background: Cell-free regenerative approaches are increasingly considered in pregnancy, where safety margins are inherently narrow and therapeutic tolerance is limited. Among these, the umbilical cord mesenchymal stem cell (UC-MSC)-derived secretome has gained attention. Still, its role at the maternal–fetal interface is not entirely straightforward, as angiogenic balance, immune tolerance, and inflammatory signaling rarely operate in isolation and tend to shift with context. Objective: To examine and integrate current evidence on UC-MSC-derived secretome in maternal–fetal interface disorders, with the aim of developing a mechanistically informed and translationally relevant framework. Methodology: This narrative review was conducted using a structured and systematic literature search informed by Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 principles to ensure transparency in study identification and selection. A total of 312 records were screened across major databases, of which 35 studies were included following full-text assessment. Given the heterogeneity in study design, experimental models, and secretome characterization, a qualitative narrative synthesis was undertaken, with selected studies presented in structured tables based on methodological clarity and relevance. Results: Across diverse models, UC-MSC-derived secretome demonstrated predominantly paracrine effects, including partial restoration of angiogenic signaling, modulation of inflammatory pathways, and influence on immune cell dynamics at the maternal–fetal interface. These effects, however, were not uniform. Variations appeared across disease states, gestational timing, and bioengineering conditions, suggesting that biological activity is context-dependent rather than fixed. Conclusion: Such variability may be functionally meaningful rather than limiting. The concept of precision perinatal secretomics is proposed, framing the secretome as a modifiable therapeutic platform that can be aligned with specific pathophysiological contexts. While clinical translation remains incomplete, this perspective offers a structured way to connect mechanistic insight with future application.

Сведения · Details